Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume 24, Issue 4, Pages 561-e20
Publisher
Wiley
Online
2017-02-22
DOI
10.1111/ene.13258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
- (2016) Ilaria Guella et al. ANNALS OF NEUROLOGY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease
- (2016) David Mengel et al. PARKINSONISM & RELATED DISORDERS
- Investigation of Genetic Variants Associated with Alzheimer Disease in Parkinson Disease Cognition
- (2016) Matthew J. Barrett et al. Journal of Parkinsons Disease
- The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
- (2016) Lucy M. Collins et al. Frontiers in Psychiatry
- Cognitive Impairments in LRRK2-Related Parkinson’s Disease: A Study in Chinese Individuals
- (2015) Yifan Zheng et al. BEHAVIOURAL NEUROLOGY
- Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson’s disease
- (2015) Silvia García et al. FOLIA NEUROPATHOLOGICA
- Genetic risk loci for Parkinson's disease: Moving from state to trait?
- (2015) Meike Kasten et al. MOVEMENT DISORDERS
- GBAVariants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
- (2015) Ignacio F. Mata et al. MOVEMENT DISORDERS
- Cognitive profile ofLRRK2-related Parkinson's disease
- (2015) Sindhu Srivatsal et al. MOVEMENT DISORDERS
- BDNF polymorphism associates with decline in set shifting in Parkinson's disease
- (2015) Nicolien M. van der Kolk et al. NEUROBIOLOGY OF AGING
- Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
- (2015) Sophie E. Winder-Rhodes et al. NEUROBIOLOGY OF AGING
- Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
- (2015) Sophia Carbutt et al. NEUROSCIENCE LETTERS
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene
- (2015) Johanne Hatteland Somme et al. PARKINSONISM & RELATED DISORDERS
- Cognitive, Neuropsychiatric, and Motor Features Associated With Apolipoprotein E ∊4 Allele in a Sample of Bulgarian Patients With Late-Onset Parkinson’s Disease
- (2014) Radka Pavlova et al. American Journal of Alzheimers Disease and Other Dementias
- Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2014) Cristina Nombela et al. BRAIN
- GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
- (2014) Kathrin Brockmann et al. MOVEMENT DISORDERS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort
- (2014) Liang Gao et al. NEUROLOGICAL SCIENCES
- BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease
- (2014) Monika Białecka et al. NEUROSCIENCE LETTERS
- Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2
- (2014) A. Estanga et al. PARKINSONISM & RELATED DISORDERS
- Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status
- (2014) Sarah E. Monsell et al. PARKINSONISM & RELATED DISORDERS
- Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
- (2014) Katerina Markopoulou et al. PARKINSONISM & RELATED DISORDERS
- Imaging endpoints for clinical trials in Alzheimer’s disease
- (2014) David M Cash et al. Alzheimers Research & Therapy
- Disease Penetrance of Late-Onset Parkinsonism
- (2014) Joanne Trinh et al. JAMA Neurology
- APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease
- (2014) Ignacio F. Mata et al. JAMA Neurology
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
- (2013) Sophie E. Winder-Rhodes et al. BRAIN
- The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
- (2013) Caroline H Williams-Gray et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals
- (2013) Chaodong Wang et al. NEUROBIOLOGY OF AGING
- Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study
- (2013) A. J. Yarnall et al. NEUROLOGY
- Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population
- (2013) Kun Nie et al. NEUROSCIENCE LETTERS
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Systematic Review and UK-Based Study ofPARK2 (parkin), PINK1, PARK7 (DJ-1)andLRRK2in early-onset Parkinson's disease
- (2012) Laura L. Kilarski et al. MOVEMENT DISORDERS
- Genetic influences on cognitive decline in Parkinson's disease
- (2012) James F. Morley et al. MOVEMENT DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- A large study reveals no association between APOE and Parkinson's disease
- (2012) Monica Federoff et al. NEUROBIOLOGY OF DISEASE
- Cognitive Impairment in Parkinsons Disease: The Dual Syndrome Hypothesis
- (2012) Angie A. Kehagia et al. Neurodegenerative Diseases
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- (2012) S. N. Gomperts et al. NEUROLOGY
- Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study
- (2012) R. N. Alcalay et al. NEUROLOGY
- Genomic determinants of motor and cognitive outcomes in Parkinson’s disease
- (2012) Sun Ju Chung et al. PARKINSONISM & RELATED DISORDERS
- Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease
- (2012) Monika Białecka et al. Pharmacogenetics and Genomics
- Dementia Risk in Parkinson Disease
- (2011) Núria Setó-Salvia et al. ARCHIVES OF NEUROLOGY
- The natural history of treated Parkinson's disease in an incident, community based cohort
- (2011) J. R. Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease
- (2011) Vicki Shanker et al. MOVEMENT DISORDERS
- Apolipoprotein E genotypes and the risk of Parkinson disease
- (2011) Jianjun Gao et al. NEUROBIOLOGY OF AGING
- Genetic variability in SNCA and Parkinson’s disease
- (2011) Lasse Pihlstrøm et al. NEUROGENETICS
- GBA-associated PD presents with nonmotor characteristics
- (2011) K. Brockmann et al. NEUROLOGY
- Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
- (2011) Samia Ben Sassi et al. PARKINSONISM & RELATED DISORDERS
- An Exploratory Study on CLU, CR1 and PICALM and Parkinson Disease
- (2011) Jianjun Gao et al. PLoS One
- Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease
- (2010) L. Gao et al. ACTA NEUROLOGICA SCANDINAVICA
- Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease
- (2010) Roy N. Alcalay et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease
- (2010) Jeroen Hoogland et al. MOVEMENT DISORDERS
- Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson’s disease in a Korean study
- (2010) Hye Guk Ryu et al. PARKINSONISM & RELATED DISORDERS
- LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
- (2010) Soreya Belarbi et al. PARKINSONISM & RELATED DISORDERS
- The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
- (2009) Caroline H. Williams-Gray et al. BRAIN
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease
- (2009) F. R. Guerini et al. EUROPEAN JOURNAL OF NEUROLOGY
- APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
- (2009) Martin Wilhelm Kurz et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease
- (2009) C. H. Williams-Gray et al. JOURNAL OF NEUROLOGY
- Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study
- (2009) Maria C. Rodriguez-Oroz et al. MOVEMENT DISORDERS
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
- (2009) L. Correia Guedes et al. PARKINSONISM & RELATED DISORDERS
- Attentional control in Parkinson's disease is dependent on COMT val158met genotype
- (2008) C. H. Williams-Gray et al. BRAIN
- Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition
- (2008) J. B. Rowe et al. BRAIN
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease
- (2008) Mario Ezquerra et al. NEUROSCIENCE LETTERS
- Alpha-synuclein promoter haplotypes and dementia in Parkinson's Disease
- (2007) E.V. De Marco et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search